{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:25:26Z","timestamp":1784690726348,"version":"3.55.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["RM12117A81AEF242"],"award-info":[{"award-number":["RM12117A81AEF242"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Foundation-Flanders","award":["1226224N"],"award-info":[{"award-number":["1226224N"]}]},{"name":"Research Foundation-Flanders","award":["1S19723N"],"award-info":[{"award-number":["1S19723N"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13346-025-01921-w","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T19:56:29Z","timestamp":1752695789000},"page":"1301-1318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advancing nanoparticle delivery studies: flow cytometry-based quantification of nanoparticle uptake and transfection in retinal tissue"],"prefix":"10.1007","volume":"16","author":[{"given":"Luca","family":"Paoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaat","family":"De Clerck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"De Coster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Matricardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Remaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2987-4938","authenticated-orcid":false,"given":"Karen","family":"Peynshaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"1921_CR1","doi-asserted-by":"crossref","unstructured":"Brandt T, Dieterich M, Huppert D. Human senses and sensors from Aristotle to the present. Front Neurol. 2024;15.","DOI":"10.3389\/fneur.2024.1404720"},{"key":"1921_CR2","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/142418a0","volume":"142","author":"RH Thouless","year":"1938","unstructured":"Thouless RH. Eye and brain as factors in visual perception. Nature. 1938;142:418\u201321.","journal-title":"Nature"},{"key":"1921_CR3","volume-title":"The neural bases of multisensory processes","author":"M Keetels","year":"2012","unstructured":"Keetels M, Vroomen J. Perception of synchrony between the senses. In: Murray MM, Wallace MT, editors. The neural bases of multisensory processes. Boca Raton (FL): CRC Press\/Taylor & Francis; 2012."},{"key":"1921_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000099236","volume-title":"Immune response and the eye","author":"HJ Kaplan","year":"2007","unstructured":"Kaplan HJ. Anatomy and function of the eye. In: Niederkorn JY, Kaplan HJ, editors. Immune response and the eye. Basel: KARGER; 2007. pp. 4\u201310."},{"key":"1921_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","volume":"9","author":"A London","year":"2013","unstructured":"London A, Benhar I, Schwartz M. The retina as a window to the brain - From eye research to CNS disorders. Nat Rev Neurol. 2013;9:44\u201353.","journal-title":"Nat Rev Neurol"},{"key":"1921_CR6","doi-asserted-by":"crossref","unstructured":"Grossniklaus HE, Geisert EE, Nickerson JM. Introduction to the retina. Prog mol biol transl sci. Elsevier B.V.; 2015. pp. 383\u201396.","DOI":"10.1016\/bs.pmbts.2015.06.001"},{"key":"1921_CR7","unstructured":"McLaughlin T, Medina A, Perkins J, Yera M, Wang JJ, Zhang SX. Cellular stress signaling and the unfolded protein response in retinal degeneration: mechanisms and therapeutic implications. Mol Neurodegener. 2022;17."},{"key":"1921_CR8","doi-asserted-by":"crossref","unstructured":"Martins B, Pires M, Ambr\u00f3sio AF, Gir\u00e3o H, Fernandes R. Contribution of extracellular vesicles for the pathogenesis of retinal diseases: shedding light on blood-retinal barrier dysfunction. J Biomed Sci. 2024;31.","DOI":"10.1186\/s12929-024-01036-3"},{"key":"1921_CR9","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","volume":"9","author":"RRA Bourne","year":"2021","unstructured":"Bourne RRA, Steinmetz JD, Saylan M, Mersha AM, Weldemariam AH, Wondmeneh TG, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health. 2021;9:e144\u201360.","journal-title":"Lancet Glob Health"},{"key":"1921_CR10","doi-asserted-by":"crossref","unstructured":"Ptito M, Bleau M, Bouskila J. The retina: A window into the brain. Cells. 2021;10.","DOI":"10.3390\/cells10123269"},{"key":"1921_CR11","unstructured":"World Health Organization. World report on vision. Geneva; 2019."},{"key":"1921_CR12","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/S2214-109X(20)30425-3","volume":"9","author":"RRA Bourne","year":"2021","unstructured":"Bourne RRA, Steinmetz JD, Flaxman S, Briant PS, Taylor HR, Resnikoff S, et al. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the global burden of disease study. Lancet Glob Health. 2021;9:e130\u201343.","journal-title":"Lancet Glob Health"},{"key":"1921_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/gt.2011.153","volume":"19","author":"KS Balaggan","year":"2012","unstructured":"Balaggan KS, Ali RR. Ocular gene delivery using lentiviral vectors. Gene Ther. 2012;19:145\u201353.","journal-title":"Gene Ther"},{"key":"1921_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jconrel.2015.10.007","volume":"219","author":"R Zulliger","year":"2015","unstructured":"Zulliger R, Conley SM, Naash MI. Non-viral therapeutic approaches to ocular diseases: an overview and future directions. J Controlled Release. 2015;219:471\u201387.","journal-title":"J Controlled Release"},{"key":"1921_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/jfb6020379","volume":"6","author":"Y Wang","year":"2015","unstructured":"Wang Y, Rajala A, Rajala R. Lipid nanoparticles for ocular gene delivery. J Funct Biomater. 2015;6:379\u201394.","journal-title":"J Funct Biomater"},{"key":"1921_CR16","doi-asserted-by":"crossref","unstructured":"Bennett J. History and development story of luxturna: scientific and regulatory challenges. In: McIntosh A, Sverdlov O, editors. Development of gene therapies. CRC Press - Taylor & Francis Group; 2024. pp. 407\u201324.","DOI":"10.1201\/9781003230342-18"},{"key":"1921_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40123-023-00862-2","volume":"13","author":"AS Brar","year":"2024","unstructured":"Brar AS, Parameswarappa DC, Takkar B, Narayanan R, Jalali S, Mandal S, et al. Gene therapy for inherited retinal diseases: from laboratory bench to patient bedside and beyond. Ophthalmol Ther. 2024;13:21\u201350.","journal-title":"Ophthalmol Ther"},{"key":"1921_CR18","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.drudis.2019.05.038","volume":"24","author":"T Bordet","year":"2019","unstructured":"Bordet T, Behar-Cohen F. Ocular gene therapies in clinical practice: viral vectors and nonviral alternatives. Drug Discov Today. 2019;24:1685\u201393.","journal-title":"Drug Discov Today"},{"key":"1921_CR19","doi-asserted-by":"crossref","unstructured":"Irigoyen C, Amenabar Alonso A, Sanchez-Molina J, Rodr\u00edguez-Hidalgo M, Lara-L\u00f3pez A, Ruiz-Ederra J. Subretinal injection techniques for retinal disease: A review. J Clin Med. 2022;11.","DOI":"10.3390\/jcm11164717"},{"key":"1921_CR20","first-page":"1308","volume":"31","author":"K Xue","year":"2017","unstructured":"Xue K, Groppe M, Salvetti AP, MacLaren RE. Technique of retinal gene therapy: delivery of viral vector into the subretinal space. Eye (Basingstoke). 2017;31:1308\u201316.","journal-title":"Eye (Basingstoke)"},{"key":"1921_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jconrel.2019.06.042","volume":"307","author":"J Devoldere","year":"2019","unstructured":"Devoldere J, Peynshaert K, Dewitte H, Vanhove C, De Groef L, Moons L, et al. Non-viral delivery of chemically modified mRNA to the retina: subretinal versus intravitreal administration. J Controlled Release. 2019;307:315\u201330.","journal-title":"J Controlled Release"},{"key":"1921_CR22","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.4103\/1673-5374.306063","volume":"16","author":"M Ross","year":"2021","unstructured":"Ross M, Ofri R. The future of retinal gene therapy: evolving from subretinal to intravitreal vector delivery. Neural Regen Res. 2021;16:1751\u20139.","journal-title":"Neural Regen Res"},{"key":"1921_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/02713683.2019.1565890","volume":"44","author":"K Peynshaert","year":"2019","unstructured":"Peynshaert K, Devoldere J, Minnaert AK, De Smedt SC, Remaut K. Morphology and composition of the inner limiting membrane: Species-Specific variations and relevance toward drug delivery research. Curr Eye Res. 2019;44:465\u201375.","journal-title":"Curr Eye Res"},{"key":"1921_CR24","doi-asserted-by":"crossref","unstructured":"Jacob S, Nair AB, Shah J, Gupta S, Boddu SHS, Sreeharsha N et al. Lipid nanoparticles as a promising drug delivery carrier for topical ocular therapy; an overview on recent advances. Pharmaceutics. 2022;14.","DOI":"10.3390\/pharmaceutics14030533"},{"key":"1921_CR25","doi-asserted-by":"crossref","unstructured":"Ryals RC, Patel S, Acosta C, McKinney M, Pennesi ME, Sahay G. The effects of pegylation on LNP based mRNA delivery to the eye. PLoS ONE. 2020;15.","DOI":"10.1371\/journal.pone.0241006"},{"key":"1921_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2023.07.028","volume":"361","author":"E Ramsay","year":"2023","unstructured":"Ramsay E, Lajunen T, Bhattacharya M, Reinisalo M, Rilla K, Kidron H, et al. Selective drug delivery to the retinal cells: biological barriers and avenues. J Controlled Release. 2023;361:1\u201319.","journal-title":"J Controlled Release"},{"key":"1921_CR27","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1038\/mt.2009.181","volume":"17","author":"D Dalkara","year":"2009","unstructured":"Dalkara D, Kolstad KD, Caporale N, Visel M, Klimczak RR, Schaffer DV, et al. Inner limiting membrane barriers to aav-mediated retinal transduction from the vitreous. Mol Ther. 2009;17:2096\u2013102.","journal-title":"Mol Ther"},{"key":"1921_CR28","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1167\/iovs.09-3884","volume":"51","author":"TV Johnson","year":"2010","unstructured":"Johnson TV, Bull ND, Martin KR. Identification of barriers to retinal engraftment of transplanted stem cells. Invest Ophthalmol Vis Sci. 2010;51:960\u201370.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1921_CR29","doi-asserted-by":"publisher","first-page":"113849","DOI":"10.1016\/j.jconrel.2025.113849","volume":"384","author":"K De Clerck","year":"2025","unstructured":"De Clerck K, De Smedt S, Remaut K, Peynshaert K. Toward successful retinal drug delivery after intravitreal injection: current strategies to overcome the inner limiting membrane. J Controlled Release. 2025;384:113849.","journal-title":"J Controlled Release"},{"key":"1921_CR30","doi-asserted-by":"crossref","unstructured":"De Clerck K, Accou G, Sauvage F, Braeckmans K, De Smedt SC, Remaut K et al. Photodisruption of the inner limiting membrane: exploring ICG loaded nanoparticles as photosensitizers. Pharmaceutics. 2022;14.","DOI":"10.3390\/pharmaceutics14081716"},{"key":"1921_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jconrel.2022.07.002","volume":"349","author":"K Peynshaert","year":"2022","unstructured":"Peynshaert K, Vanluchene H, De Clerck K, Minnaert AK, Verhoeven M, Gouspillou N, et al. ICG-mediated photodisruption of the inner limiting membrane enhances retinal drug delivery. J Controlled Release. 2022;349:315\u201326.","journal-title":"J Controlled Release"},{"key":"1921_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.addr.2017.09.007","volume":"126","author":"K Peynshaert","year":"2018","unstructured":"Peynshaert K, Devoldere J, De Smedt SC, Remaut K. In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye. Adv Drug Deliv Rev. 2018;126:44\u201357.","journal-title":"Adv Drug Deliv Rev"},{"key":"1921_CR33","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1080\/10717544.2017.1375578","volume":"24","author":"K Peynshaert","year":"2017","unstructured":"Peynshaert K, Devoldere J, Forster V, Picaud S, Vanhove C, De Smedt SC, et al. Toward smart design of retinal drug carriers: A novel bovine retinal explant model to study the barrier role of the vitreoretinal interface. Drug Deliv. 2017;24:1384\u201394.","journal-title":"Drug Deliv"},{"key":"1921_CR34","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jconrel.2024.01.063","volume":"367","author":"MB Appell","year":"2024","unstructured":"Appell MB, Pejavar J, Pasupathy A, Rompicharla SVK, Abbasi S, Malmberg K, et al. Next generation therapeutics for retinal neurodegenerative diseases. J Controlled Release. 2024;367:708\u201336.","journal-title":"J Controlled Release"},{"key":"1921_CR35","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jconrel.2020.10.028","volume":"328","author":"S Tavakoli","year":"2020","unstructured":"Tavakoli S, Peynshaert K, Lajunen T, Devoldere J, del Amo EM, Ruponen M, et al. Ocular barriers to retinal delivery of intravitreal liposomes: impact of vitreoretinal interface. J Controlled Release. 2020;328:952\u201361.","journal-title":"J Controlled Release"},{"key":"1921_CR36","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1167\/iovs.02-1068","volume":"44","author":"JL Bourges","year":"2003","unstructured":"Bourges JL, Gautier SE, Delie F, Bejjani RA, Jeanny JC, Gurny R, et al. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest Ophthalmol Vis Sci. 2003;44:3562\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1921_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/17425247.2023.2167979","volume":"20","author":"K Peynshaert","year":"2023","unstructured":"Peynshaert K, Devoldere J, De Smedt S, Remaut K. Every nano-step counts: a critical reflection on do\u2019s and don\u2019ts in researching nanomedicines for retinal gene therapy. Expert Opin Drug Deliv. 2023;20:259\u201371.","journal-title":"Expert Opin Drug Deliv"},{"key":"1921_CR38","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jconrel.2024.04.052","volume":"370","author":"S Meulewaeter","year":"2024","unstructured":"Meulewaeter S, Aernout I, Deprez J, Engelen Y, De Velder M, Franceschini L, et al. Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria. J Controlled Release. 2024;370:379\u201391.","journal-title":"J Controlled Release"},{"key":"1921_CR39","doi-asserted-by":"publisher","first-page":"6492","DOI":"10.1021\/acs.molpharmaceut.3c00956","volume":"20","author":"A-G Reinhart","year":"2023","unstructured":"Reinhart A-G, Osterwald A, Ringler P, Leiser Y, Lauer ME, Martin RE, et al. Investigations into mRNA lipid nanoparticles Shelf-Life stability under nonfrozen conditions. Mol Pharm. 2023;20:6492\u2013503.","journal-title":"Mol Pharm"},{"key":"1921_CR40","unstructured":"Limb GA, Salt TE, Munro PMG, Moss SE, Khaw PT. In vitro characterization of a spontaneously immortalized human M\u00fcller cell line (MIO-M1). Retinal Cell Biology. 2002;43."},{"key":"1921_CR41","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.2217\/nnm.12.202","volume":"8","author":"TF Martens","year":"2013","unstructured":"Martens TF, Vercauteren D, Forier K, Deschout H, Remaut K, Paesen R, et al. Measuring the intravitreal mobility of nanomedicines with Single-Particle tracking microscopy. Nanomedicine. 2013;8:1955\u201368.","journal-title":"Nanomedicine"},{"key":"1921_CR42","doi-asserted-by":"crossref","unstructured":"Subramanya S, Fernando R, Goswami M, Besirli CG, Weh E, Wubben TJ. Flow cytometric method for the detection and quantification of retinal cell death and oxidative stress. Exp Eye Res. 2023;233.","DOI":"10.1016\/j.exer.2023.109563"},{"key":"1921_CR43","doi-asserted-by":"crossref","unstructured":"Chang ZY, Lu DW, Yeh MK, Chiang CH. A novel high-content flow cytometric method for assessing the viability and damage of rat retinal ganglion cells. PLoS ONE. 2012;7.","DOI":"10.1371\/journal.pone.0033983"},{"key":"1921_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.9.9.28","volume":"9","author":"AA Brunet","year":"2020","unstructured":"Brunet AA, Fuller-Carter PI, Miller AL, Voigt V, Vasiliou S, Rashwan R, et al. Validating fluorescent chrnb4.Egfp mouse models for the study of cone photoreceptor degeneration. Transl Vis Sci Technol. 2020;9:1\u201313.","journal-title":"Transl Vis Sci Technol"},{"key":"1921_CR45","doi-asserted-by":"crossref","unstructured":"Lukowski SW, Lo CY, Sharov AA, Nguyen Q, Fang L, Hung SS et al. A single-cell transcriptome atlas of the adult human retina. EMBO J. 2019;38.","DOI":"10.15252\/embj.2018100811"},{"key":"1921_CR46","doi-asserted-by":"crossref","unstructured":"Liu B, He J, Zhong L, Huang L, Gong B, Hu J et al. Single-cell transcriptome reveals diversity of M\u00fcller cells with different metabolic-mitochondrial signatures in normal and degenerated macula. Front Neurosci. 2022;16.","DOI":"10.3389\/fnins.2022.1079498"},{"key":"1921_CR47","doi-asserted-by":"crossref","unstructured":"Bakken TE, Hodge RD, Miller JA, Yao Z, Nguyen TN, Aevermann B et al. Single-nucleus and single-cell transcriptomes compared in matched cortical cell types. PLoS ONE. 2018;13.","DOI":"10.1371\/journal.pone.0209648"},{"key":"1921_CR48","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","volume":"161","author":"EZ Macosko","year":"2015","unstructured":"Macosko EZ, Basu A, Satija R, Nemesh J, Shekhar K, Goldman M, et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell. 2015;161:1202\u201314.","journal-title":"Cell"},{"key":"1921_CR49","doi-asserted-by":"crossref","unstructured":"Garafalo AV, Cideciyan AV, H\u00e9on E, Sheplock R, Pearson A, WeiYang Yu C et al. Progress in treating inherited retinal diseases: early subretinal gene therapy clinical trials and candidates for future initiatives. Prog Retin Eye Res. 2020;77.","DOI":"10.1016\/j.preteyeres.2019.100827"},{"key":"1921_CR50","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1038\/s41467-023-42189-3","volume":"14","author":"M Gautam","year":"2023","unstructured":"Gautam M, Jozic A, Su GL-N, Herrera-Barrera M, Curtis A, Arrizabalaga S, et al. Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina. Nat Commun. 2023;14:6468.","journal-title":"Nat Commun"},{"key":"1921_CR51","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41565-023-01563-4","volume":"19","author":"J Kim","year":"2024","unstructured":"Kim J, Eygeris Y, Ryals RC, Jozi\u0107 A, Sahay G. Strategies for non-viral vectors targeting organs beyond the liver. Nat Nanotechnol. 2024;19:428\u201347.","journal-title":"Nat Nanotechnol"},{"key":"1921_CR52","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jconrel.2013.01.018","volume":"167","author":"Q Xu","year":"2013","unstructured":"Xu Q, Boylan NJ, Suk JS, Wang Y-Y, Nance EA, Yang J-C, et al. Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo. J Controlled Release. 2013;167:76\u201384.","journal-title":"J Controlled Release"},{"key":"1921_CR53","doi-asserted-by":"crossref","unstructured":"Pitkanen L, Pelkonen J, Ruponen M, Ronkko S, Urtti A. Neural retina limits the Non viral gene transfer to retinal pigment epithelium in an in vitro bovine eye model. AAPS J. 2004;6.","DOI":"10.1208\/aapsj060325"},{"key":"1921_CR54","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1016\/j.biomaterials.2012.01.030","volume":"33","author":"H Koo","year":"2012","unstructured":"Koo H, Moon H, Han H, Na JH, Huh MS, Park JH, et al. The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection. Biomaterials. 2012;33:3485\u201393.","journal-title":"Biomaterials"},{"key":"1921_CR55","doi-asserted-by":"crossref","unstructured":"Peynshaert K, Fradot V, Picaud S, De Smedt S, Remaut K. Toward rational design of gene carriers: a novel ex vivo model to study the vitreoretinal interface as a barrier. Acta Ophthalmol. 2016;94.","DOI":"10.1111\/j.1755-3768.2016.0376"},{"key":"1921_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejpb.2019.05.023","volume":"141","author":"J Devoldere","year":"2019","unstructured":"Devoldere J, Wels M, Peynshaert K, Dewitte H, De Smedt SC, Remaut K. The obstacle course to the inner retina: hyaluronic acid-coated lipoplexes cross the vitreous but fail to overcome the inner limiting membrane. Eur J Pharm Biopharm. 2019;141:161\u201371.","journal-title":"Eur J Pharm Biopharm"},{"key":"1921_CR57","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/BF02150029","volume":"224","author":"S Heegaard","year":"1986","unstructured":"Heegaard S, Jensen OA, Prause JU. Structure and composition of the inner limiting membrane of the retina. SEM on frozen resin-cracked and enzyme-digested retinas of Macacca mulatta. Graefe\u2019s Arch Clin Exp Ophthalmol. 1986;224:355\u201360.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"1921_CR58","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.stemcr.2020.12.001","volume":"16","author":"KY Zhang","year":"2021","unstructured":"Zhang KY, Tuffy C, Mertz JL, Quillen S, Wechsler L, Quigley HA, et al. Role of the internal limiting membrane in structural engraftment and topographic spacing of transplanted human stem Cell-Derived retinal ganglion cells. Stem Cell Rep. 2021;16:149\u201367.","journal-title":"Stem Cell Rep"},{"key":"1921_CR59","doi-asserted-by":"crossref","unstructured":"Chen S, Deng Z, Ji D. Advances in the development of lipid nanoparticles for ophthalmic therapeutics. Biomed Pharmacotherapy. 2024;178.","DOI":"10.1016\/j.biopha.2024.117108"},{"key":"1921_CR60","doi-asserted-by":"publisher","first-page":"e0241006","DOI":"10.1371\/journal.pone.0241006","volume":"15","author":"RC Ryals","year":"2020","unstructured":"Ryals RC, Patel S, Acosta C, McKinney M, Pennesi ME, Sahay G. The effects of pegylation on LNP based mRNA delivery to the eye. PLoS ONE. 2020;15:e0241006.","journal-title":"PLoS ONE"},{"key":"1921_CR61","doi-asserted-by":"crossref","unstructured":"Chatterjee S, Kon E, Sharma P, Peer D. Endosomal escape: A bottleneck for LNP-mediated therapeutics. Proceedings of the National Academy of Sciences. 2024;121.","DOI":"10.1073\/pnas.2307800120"},{"key":"1921_CR62","doi-asserted-by":"crossref","unstructured":"Liu H, Chen MZ, Payne T, Porter CJH, Pouton CW, Johnston APR. Beyond the endosomal bottleneck: Understanding the efficiency of mRNA\/LNP delivery. Adv Funct Mater. 2024;34.","DOI":"10.1002\/adfm.202404510"},{"key":"1921_CR63","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jcis.2024.06.158","volume":"674","author":"R M\u00fcnter","year":"2024","unstructured":"M\u00fcnter R, Larsen JB, Andresen TL. The vast majority of nucleic acid-loaded lipid nanoparticles contain cargo. J Colloid Interface Sci. 2024;674:139\u201344.","journal-title":"J Colloid Interface Sci"},{"key":"1921_CR64","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jconrel.2024.07.046","volume":"373","author":"JB Simonsen","year":"2024","unstructured":"Simonsen JB. A perspective on bleb and empty LNP structures. J Controlled Release. 2024;373:952\u201361.","journal-title":"J Controlled Release"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01921-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01921-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01921-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:02:37Z","timestamp":1772553757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01921-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1921"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01921-w","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"9 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures involving cell lines were conducted following institutional guidelines and approved protocols. No human or live animal studies were performed, and thus specific ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}